FDA Approval to Advance Final FemBloc® Trial with Clear Pathway to Potentially Achieve U.S. FDA Approval – – $12 Million Financing Strengthens Balance Sheet and Extends Cash Runway – ATLANTA, Nov. 14, ...
A Conference call is scheduled for Monday, november 17, 2025, 11:00am ET See dial in number below TABER, ALBERTA, Nov. 14, 2025 (GLOBE NEWSWIRE) -- FLEXIBLE SOLUTIONS INTERNATIONAL, INC. (NYSE Amex: ...
Third Quarter Net Sales and Adjusted EBITDA Exceeded Guidance Driven by 44% OEM Growth Gross Margin Expanded 710 Basis Points Year-over-Year ...
Third Quarter Net Sales and Adjusted EBITDA Exceeded Guidance Driven by 44% OEM GrowthGross Margin Expanded 710 Basis Points Year-over-YearRecent Public Offerings and Debt Restructuring Significantly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback